- Report
- August 2024
- 185 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- November 2024
- 175 Pages
Global
From €4739EUR$5,000USD£3,959GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1896EUR$2,000USD£1,584GBP
- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- August 2024
- 85 Pages
United Kingdom
From €3317EUR$3,500USD£2,771GBP
Monkeypox is a rare viral infection caused by the monkeypox virus. It is closely related to the smallpox virus, and is found mainly in Central and West African countries. Treatment for monkeypox is similar to that of smallpox, and includes antiviral drugs such as cidofovir, vaccinia immune globulin, and ribavirin. These drugs are used to reduce the severity of the infection and to prevent further spread of the virus.
Infectious diseases drugs are used to treat a wide range of illnesses, including monkeypox. The market for these drugs is highly competitive, with many companies offering a variety of treatments. Some of the major players in the monkeypox drug market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. These companies are actively researching and developing new treatments for monkeypox, as well as other infectious diseases. Show Less Read more